Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.
Bautista
Edgar
E
Chotpitayasunondh
Tawee
T
Gao
Zhancheng
Z
Harper
Scott A
SA
Shaw
Michael
M
Uyeki
Timothy M
TM
Zaki
Sherif R
SR
Hayden
Frederick G
FG
Hui
David S
DS
Kettner
Joel D
JD
Kumar
Anand
A
Lim
Matthew
M
Shindo
Nahoko
N
Penn
Charles
C
Nicholson
Karl G
KG
D000956:Antigens, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification / Q000472:pathogenicity; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000473:pathology; D053139:Oseltamivir / Q000627:therapeutic use; D012367:RNA, Viral / Q000032:analysis; D012307:Risk Factors; D012720:Severity of Illness Index
D000956:Antigens, Viral; D000998:Antiviral Agents; D012367:RNA, Viral; D053139:Oseltamivir